Structural basis for the action of drugs that affect microtubule dynamics

Expert Opinion on Therapeutic Targets

Volumn 4, Issue 2, 2000, Pages 219-237

  Downing, Kenneth H ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

antimitotic drugs; benzimidazoles; colchicine; dinitroanilines; dynamic instability; microtubules; Taxol (paclitaxel); tubulin; vinblastine

Indexed keywords

EID: 0000122599     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.4.2.219     Document Type: Review

References (70)

1. JORDAN MA, WILSON L: Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr. Opin. Cell Biol. (1998) 10:123-130. (Pubitemid 28066130)
2. NOGALES E, WOLF SG, DOWNING KH: Structure of the tubulin dimer by electron crystallography. Nature (1998) 391:199-203. (Pubitemid 28092482)
3. MANDELKOW E-M, MANDELKOW E, MILLIGAN RA: Microtubule dynamics and microtubule caps: a time-resolved cryo-electron microscopy study. J. Cell Biol. (1991) 114:977-991. (Pubitemid 21909861)
4. MULLER-REICHERT T, CHRÉTIEN D, SEVERIN F, HYMAN AA: Structural changes at microtubule ends accompanying GTP hydrolysis: information from a slowly hydrolyzable analogue of GTP, guanylyl (alpha,beta) methylenediphosphonate. Proc. Natl. Acad. Sci. USA (1998) 95:3661-3666. (Pubitemid 28173184)
5. NOGALES E, WHITTAKER M, MILLIGAN RA, DOWNING KH: High resolution model of the microtubule. Cell (1999) 96:79-88.
6. LUDUEÑA RF: The multiple forms of tubulin: different gene products and covalent modifications. Int. Rev. Cyt. (1998) 178:207-275. (Pubitemid 128717548)
7. LU Q, LUDUENA RF: In vitro analysis of microtubule assembly of isotypically pure tubulin dimers. Intrinsic differences in the assembly properties of alpha beta II, alpha beta III and alpha beta IV tubulin dimers in the absence of microtubule-associated proteins. J. Biol. Chem. (1994) 269:2041-2047.
8. LÖWE J, AMOS LA: Crystal structure of the bacterial cell division protein FtsZ. Nature (1998) 391:203-206. (Pubitemid 28092483)
9. RAYCHAUDHURI D, PARK JT: Escherichia coli cell-division gene FtsZ encodes a novel GTP-binding protein. Nature (1992) 359:251-254.
10. ERICKSON HP: FtsZ, a prokariotic homolog of tubulin? Cell (1995) 80:367-370.
11. NOGALES E, DOWNING K, AMOS L, LÖWE, J: Tubulin and FtsZ form a distinct family of GTPases. Nature Struct. Biol. (1998) 5:451-458. (Pubitemid 28265028)
12. RICHARDS K, ANDERS KR, NOGALES E, SCHWARTZ K, DOWNING KH, BOTSTEIN D: Systematic mutagenesis of the alpha-tubulin gene TUB1 in Saccharomyces cerevesia. Mol. Biol. Cell (2000) (In Press).
13. DAI K, MUKHERJEE A, XU Y, LUTKENHAUS J: Mutations in FtsZ that confer resistance to SulA affect the interaction of FtsZ with GTP. J. Bacteriol. (1994) 175:130-136. (Pubitemid 24014931)
14. SACKETT DL: Structure and function in the tubulin dimer and the role of the acidic carboxyl terminus. In: Subcellular Biochemistry, Volume 24. BB Biswas, S Roy (Eds), Plenum Press, New York, USA (1995):255-302.
15. WHITE EA, BURTON PR, HIMES RH: Polymorphic assembly of subtilisin-cleaved tubulin. Cell Motil. Cytoskel. (1987) 7:31-38.
16. WOLFF J: Promotion of microtubule assembly by oligocations: cooperativity between charged groups. Biochemistry (1998) 37:10722-10729. (Pubitemid 28357873)
17. HAMEL E: Antimitotic natural products and their interactions with tubulin. Med. Res. Rev. (1996) 16:207-231. (Pubitemid 26099989)
18. VON ANGERER E: New inhibitors of tubulin polymerisation. Exp. Opin. Ther. Patents (1999) 9(8):1069-1081.
19. SCHIFF PB, FANT J, HORWITZ SB: Promotion of microtubule assembly in vitro by Taxol. Nature (1979) 277:665-667. (Pubitemid 9114288)
20. RAO S, KRAUSS NE, HEERDING JM, ORR GA, HORWITZ SB: 3-′p- Azidobenzamido)taxol photolabels the N-terminal 31 amino acids of β-tubulin. J. Biol. Chem. (1994) 269:3132-3134.
21. RAO S, ORR GA, CHAUDHARY AG, KINGSTON DGI, HORWITZ SB: Characterization of the Taxol binding site on the microtubule: 2-(m-azidobenzoyl)taxol photolabels a peptide (amino acids 217-231) of β-tubulin. J. Biol. Chem. (1995) 270:20235-20238.
22. WILLIAMS HJ, SCOTT AI, DIEDEN RA: NMR and molecular modeling study of the conformations of Taxol and of its side chain methylester in aqueous and non-aqueous solution. Tetrahedron (1993) 49:6556-6560.
23. SNYDER JP, NETTLES J, CORNETT B, DOWNING KH, NOGALES E: Binding conformation of paclitaxel, epothilone B and sarcodictyin A in the alpha-beta tubulin dimer and a mechanism for lateral tubulin polymerization. Proc. Natl. Acad. Sci. USA (2000). Submitted.
24. AMOS L, LÖWE J: How Taxol stabilizes microtubule structure. Chem. Biol. (1999) 6:R65-R69. (Pubitemid 29363146)
25. BALOGLU E, KINGSTON DGI: The taxane diterpenoids. J. Nat. Prod. (1999) 62:1448-1472. (Pubitemid 29504118)
26. EARHART RH: Taxotere (docetaxel): preclinical and general clinical information. Sem. Oncol. (1999) 26:8-13. (Pubitemid 30000738)
27. RINGEL I, HORWITZ SB: Studies with Rp-56976 (Taxotere)-a semisynthetic analogue of Taxol. J. Natl. Cancer Inst. (1991) 83:288-291.
28. KINGSTON DGI: Taxol: the chemistry and structureactivity relationships of a novel anticancer agent. Trends Biotechnol. (1994) 12:222-227.
29. KAVALLARIS M, KUO DY-S, BURKHART CA et al.: Taxolresistant epithelial ovarian tumors are associated with altered expression of specific β-tubulin isotypes. J. Clin. Invest. (1997) 100:1282-1293. (Pubitemid 27386315)
30. DUMONTET C, DURAN GE, STEGER KA, BEKETICORESKOVIC L, SIKIC BI: Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol). Cancer Res. (1996) 56:1091-1097. (Pubitemid 26065405)
31. KAVALLARIS M, BURKHART CA, HORWITZ SB: Antisense oligonucleotides to class III beta-tubulin sensitize drug-resistant cells to Taxol. Br. J. Cancer (1999) 80:1020-1025. (Pubitemid 29233923)
32. GIANNAKAKOU P, SACKETT DL, KANG Y-K et al.: Paclitaxel-resistant human ovarian cancer cells have mutant β-tubulins that exhibit impaired paclitaxeldriven polymerization. J. Biol. Chem. (1997) 272:17118-17125. (Pubitemid 27289821)
33. BOLLAG DM, MCQUENEY PA, ZHU J et al.: Epothilones, a new class of microtubule-stabilizing agents with a Taxol-like mechanism of action. Cancer Res. (1995) 55:2325-2333.
34. TER HAAR E, KOWALSKI RJ, HAMEL E et al.: Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than Taxol. Biochemistry (1996) 35:243-250. (Pubitemid 26037301)
35. LINDEL T, JENSEN PR, FENICAL W et al.: Eleutherobin, a new cytotoxin that mimics paclitaxel (Taxol) by stabilizing microtubules. J. Am. Chem. Soc. (1997) 119:8744-8745. (Pubitemid 27406321)
36. KETZINEL S, RUDI A, SCHLEYER M, BENAYAHU Y, KASHMAN Y: Sarcodictyin A and two novel diterpenoid glycosides, eleuthosides A and B, from the soft coral Eleutherobia aurea. J. Natl. Prod. (1996) 59:873-875. (Pubitemid 26337509)
37. GIANNAKAKOU P, GUSSIO R, NOGALES E et al.: A common pharmacophore for epothilone and Taxol: molecular basis for drug-resistance-conferred by tubulin mutations in human cancer cells. Proc. Natl. Acad. Sci. USA (2000) 97:2904-2909. (Pubitemid 30159270)
38. BALLONE P, MARCHI M: A density functional study of a new family of anticancer drugs: paclitaxel, docetaxel, epothilone and discodermolide. J. Phys. Chem. A (1999) 103:3097-3102.
39. DOWNING KH, NOGALES E: New insights into microtubule structure and function from the atomic model of tubulin. Eur. Biophys. J. (1998) 27:431-436. (Pubitemid 28414883)
40. UPPULURI S, KNIPLING L, SACKETT, DL, WOLFF J: Localization of the colchicine-binding site of tubulin. Proc. Natl. Acad. Sci. USA (1993) 90:11598-11602. (Pubitemid 24008686)
41. BAI R, PEI X, BOYE Oet al.: Identification of cysteine 354 of β-tubulin as part of the binding site for the A ring of colchicine. J. Biol. Chem. (1996) 271:12639-12645. (Pubitemid 26160939)
42. HAN Y, MALAK H, CHAUDHARY A, CHORDIA M, KINGSTON D, BANE S: Distances between the paclitaxel, colchicine and exchangeable GTP binding sites on tubulin. Biochemistry (1998) 37:6636-6644. (Pubitemid 28228097)
43. LI YK, POLIKS B, CEGELSKI L et al.: Conformation of microtubule-bound paclitaxel determined by fluorescence spectroscopy and REDOR NMR. Biochemistry (2000) 39:281-291. (Pubitemid 30056461)
44. GARLAND DL: Kinetics and mechanisms of colchicine binding to tubulin: evidence for ligand-induced conformational change. Biochemistry (1978) 17:4266-4272. (Pubitemid 9037191)
45. LAMBEIR A, ENGELBORGHS Y: A fluorescence stopped flow study of colchicine binding to tubulin. J. Biol. Chem. (1981) 256:3279-3282. (Pubitemid 11076987)
46. ENGELBORGHS Y: General features of the recognition by tubulin of colchicine and related compounds. Eur. Biophys. J. (1998) 27:437-445. (Pubitemid 28414884)
47. CHEN XY, PINE P, KNAPP AM, TUSE D, LADEROUTE KR: Oncocidin A1: a novel tubulin-binding drug with antitumor activity against human breast and ovarian carcinoma xenografts in nude mice. Biochem. Pharmacol. (1998) 56:623-633. (Pubitemid 28458901)
48. CUSHMAN M, HE HM, KATZENELLENBOGEN JA, LIN CM, HAMEL E: Synthesis, antitubulin and antimitotic activity and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site. J. Med. Chem. (1995) 38:2041-2049.
49. SHAN B, MEDINA JC, SANTHA E et al.: Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with an in vivo efficacy against multidrug-resistant tumors. Proc. Natl. Acad. Sci. USA (1999) 96:5686-5691. (Pubitemid 29234679)
50. DETRICH HW, WILLIAMS RC, WILSON L: Effect of colchicine binding on the reversible disassociation of the tubulin dimer. Biochemistry (1982) 21:2392-2400. (Pubitemid 12065042)
51. SACKETT DL, VARMA JK: Molecular mechanism of colchicine action: induced local unfolding of β-tubulin. Biochemistry (1993) 32:13560-13565. (Pubitemid 24020232)
52. HEUSÈLE C, CARLIER MF: GTPase activity of the tubulincolchicine in relation with tubulin-tubulin interactions. Biochem. Biophys. Res. Comm. (1981) 103:332-338. (Pubitemid 12211101)
53. WILSON L, PANDA D, JORDAN MA: Modulation of microtubule dynamics by drugs: a paradigm for the actions of cellular regulators. Cell Struct. Funct. (1999) 24:329-335.
54. ERICKSON HP: Negatively stained vinblastine aggregates. Ann. NY Acad. Sci. (1975) 253:51-52.
55. DOWNING KH, NOGALES E: Crystallographic structure of tubulin: implications for dynamics and drug binding. Cell Struct. Funct. (1999) 24:269-275.
56. RAI SS, WOLFF, J: Localization of the vinblastinebinding site on β-tubulin. J. Biol. Chem. (1996) 271:14707-14711.
57. LOBERT S, INGRAM JW, HILL BT, CORREIA JJ: A comparison of thermodynamic parameters for vinorelbine and vinflunine-induced tubulin self-association by sedimentation velocity. Mol. Pharmacol. (1998) 53:908-915. (Pubitemid 28244079)
58. VERDIER-PINARD P, GARES M, WRIGHT, M: Differential in vitro association of vinca alkaloid-induced tubulin spiral filaments into aggregated spirals. Biochem. Pharmacol. (1999) 58:959-971. (Pubitemid 29361462)
59. LOBERT S, FRANKFURTER A, CORREIA JJ: Energetics of vinca alkaloid interactions with tubulin isotypes: implications for drug efficacy and toxicity. Cell Motil. Cytoskel. (1998) 39:107-121. (Pubitemid 28079642)
60. BAI R, PETTIT GR, HAMEL E: Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and vinca alkaloid sites. J. Biol. Chem. (1990) 265:17141-17149.
61. BAI RE, KEPLER JA, PETTIT GR, HAMEL E: Characterization of the interaction of cryptophycin 1 with tubulin: binding in the Vinca domain, competitive inhibition of dolastatin 10 binding and an unusual aggregation reaction. Cancer Res. (1996) 56:4398-4406. (Pubitemid 26330447)
62. SMITH CD, ZHANG XQ, MOOBERRY SL, PATTERSON GML, MOORE RE: Cryptophycin-a new antimicrotubule agent active against drug-resistant cells. Cancer Res. (1994) 54:3779-3784. (Pubitemid 24241196)
63. REIJO RA, COOPER EM, BEAGLE GJ, HUFFAKER TC: Systematic mutational analysis of the yeast beta-tubulin gene. Mol. Biol. Cell (1994) 5:29-43. (Pubitemid 24062030)
64. JUNG MK, WILDER IB, OAKLEY BR: Amino acid alterations in the benA (beta-tubulin) gene of Aspergillus nidulans that confer benomyl resistance. Cell Motil. Cytoskel. (1992) 22:170-174.
65. ALBERTINI C, GREDT M, LEROUX P: Mutations of the beta-tubulin gene associated with different phenotypes of benzimidazole resistance in the cereal eyespot fungi Tapesia yallundae and Tapesia acuformis. Pesticide Biochem. Physiol. (1999) 64:17-31. (Pubitemid 29405343)
66. JUNG MK, OAKLEY BR: Identification of an amino acid substitution in the benA (beta-tubulin) gene of Aspergillus nidulans that confers thiabendazole resistance and benomyl supersensitivity. Cell Motil. Cytoskel. (1990) 17:87-94. (Pubitemid 20372176)
67. CHAN MMY, GROGL M, CHEN CC, BIENEN EJ, FONG D: Herbicides to curb human parasitic infections-in vitro and in vivo effects of trifluralin on the trypanosomatid protozoans. Proc. Natl. Acad. Sci. USA (1993) 90:5657-5661. (Pubitemid 23176220)
68. ANTHONY RG, HUSSEY PJ: Double mutation in Eleusine indica alpha-tubulin increases the resistance of transgenic maize calli to dinitroaniline and phosphorothioamidate herbicides. Plant J. (1999) 18:669-674.
69. TRAUB-CSEKO YM, RAMALHO-ORTIGÃO JM, DANTAS AP, DE CASTRO SL, BARBOSA HS, DOWNING KH: Dinitroaniline herbicides against protozoan parasites: how do they work? The case of Trypanosoma cruzi. Parasitol. Today (2000) (In Press).
70. SCHONBRUNN E, PHLIPPEN W, TRINCZEK B et al.: Crystallization of a macromolecular ring assembly of tubulin liganded with the anti-mitotic drug podophyllotoxin. J. Struct. Biol. (1999) 128:211-215. (Pubitemid 30039062)